Katherine Goodrich

Insider Reports History

Location
Irvine, CA
Signature
/s/ Scott Sieckert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Katherine Goodrich:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Director Common Stock 2,233 $182,841 $81.88 15 Dec 2025 Direct
Tarsus Pharmaceuticals, Inc. Director Restricted Stock Units 4,467 $177,751 $26.53 15 Dec 2025 Direct
Tarsus Pharmaceuticals, Inc. Director Stock Option (right to buy) 4,540 $109,900 $10.99 12 Jun 2025 Direct

Insider Reports Filed by Katherine Goodrich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARS Tarsus Pharmaceuticals, Inc. 15 Dec 2025 2 $0 4 Director 14 Jan 2026, 19:32
TARS Tarsus Pharmaceuticals, Inc. 12 Jun 2025 2 $0 4 Director 16 Jun 2025, 16:05
TARS Tarsus Pharmaceuticals, Inc. 13 Nov 2024 2 $0 4 Director 15 Nov 2024, 16:37
TARS Tarsus Pharmaceuticals, Inc. 13 Nov 2024 0 $0 3 Director 15 Nov 2024, 16:36